SCHEMBL12197682

SCHEMBL12197682

CC(O)(c1ccc(O)cc1O)C(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
ALOX15 P16050 2/20 0.47
TYR P14679 2/20 0.47
NR1I2 O75469 1/20 0.47
LMNA P02545 1/20 0.47
CYP2C9 P11712 1/20 0.47
MIF P14174 1/20 0.47
HTT P42858 1/20 0.47
NFE2L2 Q16236 1/20 0.47
HSD17B10 Q99714 1/20 0.47
AR P10275 3/20 0.43
KCNJ11 Q14654 1/20 0.40
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.39
MAPT P10636 1/20 0.39
ATP2A2 P16615 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ATP2A3 Q93084 1/20 0.39
HSP90AA1 P07900 1/20 0.39
PDK1 Q15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18399466 0.84 ESR1 (0.52) ALDH1A1ALOX15TYRNR1I2LMNA
SCHEMBL17286693 0.83 ALDH1A1 (0.48) ALDH1A1ALOX15TYRLMNAHSD17B10
SCHEMBL17286684 0.82 AR (0.46) ALDH1A1ALOX15TYRNR1I2LMNA
SCHEMBL2506023 0.81 KCNJ11 (0.47) ALDH1A1ALOX15TYRNR1I2LMNA
SCHEMBL17286715 0.80 ALDH1A1 (0.44) ALDH1A1ALOX15TYRNR1I2LMNA
SCHEMBL7949470 0.80 ALDH1A1 (0.52) ALDH1A1ALOX15TYRNR1I2LMNA
SCHEMBL15496927 0.78 TRPA1 (0.41) ALDH1A1ALOX15TYRNR1I2LMNA
SCHEMBL15582360 0.78 HSP90AA1 (0.40) ALDH1A1ALOX15TYRNR1I2LMNA
SCHEMBL4184980 0.78 KIF11 (0.50) ALDH1A1ALOX15TYRNR1I2LMNA
SCHEMBL278382 0.78 ALDH1A1 (0.54) ALDH1A1ALOX15TYRNR1I2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9678425-B2 Polymerizable fluoromonomer, fluoropolymer, resist material, and method of pattern formation CENTRAL GLASS COMPANY, LIMITED (JP) 2017-06-13 US disclosed
US-9678426-B2 Polymerizable fluoromonomer, fluoropolymer, resist material, and method of pattern formation CENTRAL GLASS COMPANY, LIMITED (JP) 2017-06-13 US disclosed
US-9464163-B2 Novolak resin containing hexafluoroisopropanol group, method for producing same, and composition of same CENTRAL GLASS COMPANY, LIMITED (JP) 2016-10-11 US disclosed
US-20150337077-A1 Novolak Resin Containing Hexafluoroisopropanol Group, Method for Producing Same, and Composition of Same CENTRAL GLASS COMPANY, LIMITED (JP) 2015-11-26 US disclosed
US-20140221589-A1 Polymerizable Fluoromonomer, Fluoropolymer, Resist Material, and Method of Pattern Formation CENTRAL GLASS COMPANY, LIMITED (JP) 2014-08-07 US disclosed
US-20140220490-A1 Polymerizable Fluoromonomer, Fluoropolymer, Resist Material, and Method of Pattern Formation CENTRAL GLASS COMPANY, LIMITED (JP) 2014-08-07 US disclosed
US-20110245395-A1 Top Coat Composition CENTRAL GLASS COMPANY, LIMITED 2011-10-06 US disclosed
US-20110244188-A1 Polymerizable Fluoromonomer, Fluoropolymer, Resist Material, and Method of Pattern Formation Central Glass Company , Limited (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110244188-A1 Polymerizable Fluoromonomer, Fluoropolymer, Resist Material, and Method of Pattern Formation AFF1, FRG1, AFF2 ALDH1A1 2056/4885ALOX15 4213/4885TYR 4845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.